• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: Autologous incubated macrophage
Date Designated: 09/03/2004
Orphan Designation: Therapy to improve the motor and sensory neurological outcome in acute cases of spinal cord injury
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Proneuron Biotechnologies, Inc.
2029 Century Park East
Sixth Floor
Los Angeles, California 90067
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-